Patents by Inventor Arnaud Hamel

Arnaud Hamel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9150571
    Abstract: This invention relates to the discovery of novel forms of Compound 1, including solvates, hydrates, and other crystalline forms. These novel forms of Compound 1 may impart advantages in pharmaceutical formulations incorporating them, including improved stability and bioavailability.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: October 6, 2015
    Assignee: Curis, Inc.
    Inventors: Noel Hamill, James Moody, Sébastien Chabaud, Arnaud Hamel
  • Publication number: 20140088138
    Abstract: This invention relates to the discovery of novel forms of Compound 1, including solvates, hydrates, and other crystalline forms. These novel forms of Compound 1 may impart advantages in pharmaceutical formulations incorporating them, including improved stability and bioavailability.
    Type: Application
    Filed: September 23, 2013
    Publication date: March 27, 2014
    Applicant: Debiopharm International SA
    Inventors: Noel Hamill, James Moody, Sébastien Chabaud, Arnaud Hamel
  • Publication number: 20040138108
    Abstract: The invention relates to a pro-drug comprising a cyclic undecapeptide wherein the peptide chain thereof comprises at least one amino acid residue of general formula (1) wherein the carbon atom Ca is one of the links in said undecapeptide cycle; —substituents Y individually represent a hydrogen atom or form a bond together; —substitutents R1 and R3 independently represent a hydrogen atom, an aralkyl group, an alkaryl group, a heteroalkyl group, a heterocyclic group, a heterocyclic alkyl group, an alkyl heterocyclic group or an alkyl group having 1-6 carbon atoms which is linear or branched, and which is optionally substituted by at least one of the groups chosen from among —COOH, —CONHR8, —NHCO═NH(NH2), —NHC═NR8(NH2), —NH2, —NHR8, —NR82, —N+R83, —OH, —OPO(OR8)2, —OPO(OH)(OR8), —OPO(OH)2, —OSO(OR8)2, —OSO(OH)(OR8), —OSO(OH)2, and the different salts produced therefrom, each of the substituents R8
    Type: Application
    Filed: October 9, 2003
    Publication date: July 15, 2004
    Inventors: Roland Wenger, Manfred Mutter, Arnaud Hamel, Francis Hubler